HEPARIN SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Heparin Sodium patents expire, and what generic alternatives are available?
Heparin Sodium is a drug marketed by Abraxis Pharm, B Braun Medical Inc, Be Pharms, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Dr Reddys, Epic Pharma Llc, Fresenius Kabi Usa, Gland, Hikma, Hospira, Hospira Inc, Lilly, Luitpold, Mylan Labs Ltd, Nanjing King-friend, Organon Usa Inc, Parke Davis, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Smith And Nephew, Solopak, Watson Labs Inc, Baxter Hlthcare, Mcgaw, B Braun, and Pharma Serve Ny. and is included in sixty-nine NDAs.
The generic ingredient in HEPARIN SODIUM is heparin sodium. There are seventy-seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Heparin Sodium
A generic version of HEPARIN SODIUM was approved as heparin sodium by HOSPIRA on April 28th, 1983.
Summary for HEPARIN SODIUM
US Patents: | 0 |
Applicants: | 32 |
NDAs: | 69 |
Finished Product Suppliers / Packagers: | 17 |
Clinical Trials: | 98 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for HEPARIN SODIUM |
What excipients (inactive ingredients) are in HEPARIN SODIUM? | HEPARIN SODIUM excipients list |
DailyMed Link: | HEPARIN SODIUM at DailyMed |
Recent Clinical Trials for HEPARIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Prevail Infoworks, Inc | Phase 2 |
Vaneltix Pharma, Inc. | Phase 2 |
The First Affiliated Hospital with Nanjing Medical University | N/A |
Pharmacology for HEPARIN SODIUM
Drug Class | Anti-coagulant Unfractionated Heparin |
Anatomical Therapeutic Chemical (ATC) Classes for HEPARIN SODIUM
US Patents and Regulatory Information for HEPARIN SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nanjing King-friend | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 211005-001 | Dec 14, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sandoz | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 091682-001 | Jun 8, 2011 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Fresenius Kabi Usa | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 017651-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Epic Pharma Llc | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 017486-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |